Business
Progress update on CANTABmobileT
Progress update on CANTABmobileT.
About this update from Cambridge Cognition Holdings Plc
[{"type":"text","content":"\n \nRNS Number : 8537H Cambridge Cognition Holdings PLC 26 June 2013 \n \n\n\nCambridge Cognition Holdings Plc \n('Cambridge Cognition' or the 'Company')\n \nProgress update on CANTABmobile™\n \nCambridge Cognition Holdings plc, (AIM: COG), which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, is pleased to provide an update on its CANTABmobile™ product after the Company's admission to AIM on 18 April 2013. \n \nCANTABmobile is an approved CE-marked Class II medical device, which addresses the need to rapidly detect early memory loss or signs of cognitive impairment. The product, which runs on an iPad, is targeted at mainstream primary healthcare markets and is based on tests previously only available, through the Company's other product offerings, to pharmaceutical companies and academia for specialist trials and research. \n \nGuildford and Waverley CCG is the latest clinical commissioning group (\"CCG\") to roll out CANTABmobile into GP practices, whilst trials of CANTABmobile continue with over 60 CCGs around the UK. Currently CANTABmobile™ has 16 customers, including 6 CCGs, as well as a number of private healthcare groups and a pharmacy chain, each in the UK, and a clinical centre in Germany. \n \nOngoing trials with CCGs are expected to convert into licence sales in the coming months as a dedicated sales and marketing function for CANTABmobile is established, and discussions continue with a number of possible channel partners to help accelerate the adoption of CANTABmobile™ in the UK and beyond. The build-up of this sales and marketing function continues in line with expectations, with four new sales hires joining shortly, and the Company looks forward to appointing a senior sales manager in due course. The Company anticipates that the benefit of this investment will be seen as the Company enters the second half of the financial year. \nCommenting, Ruth Keir, Chief Executive Officer of Cambridge Cognition, said: \"We are delighted to announce that Guildford and Waverley is an early adopter of CANTABmobile. There has been significant interest in the UK primary care sector for our technology, with over 60 CCGs current trialling the software, but it is also pleasing to see our customer base diversifying beyond this market. Our prog...